海马 3D Mito 压力测定在患者衍生的儿科脑瘤单个神经圈的协议
bioRxiv : the preprint server for biology
|January 23, 2026
概括
这项研究详细介绍了一种海马测试方案,用于测量3D培养中单个脑瘤神经圈的新陈代谢. 优化的方法允许分析患者衍生的瘤中的动态代谢变化.
科学领域:
- 生物化学 生化学
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 细胞代谢对功能至关重要,在癌症中经常受到调节失调.
- 海马测试是2D细胞代谢的标准,但对于3D模型来说具有挑战性.
- 脑瘤神经圈代表了研究脑癌的相关3D模型.
研究的目的:
- 建立一个强大的协议,将海马测试应用到来自单个患者的脑瘤神经圈.
- 为了使3D脑瘤模型中生物能量的测量.
- 为了促进对应干预的代谢变化的研究.
主要方法:
- 开发了一种逐步的协议,用于将单个脑瘤神经圈重新和转移到海马测试微板中.
- 优化了微板涂层技术,以提高球形粘附和测试性能.
- 在测试前后实施成像,以根据神经圈大小将代谢数据正常化.
主要成果:
- 成功地调整了海马试验单个脑瘤神经圈.
- 提供了关键建议,并确定了协议执行的潜在陷.
- 在3D脑瘤模型中测量动态代谢变化的可行性.
结论:
- 提出的协议有效地测量了单个脑瘤神经圈的生物能量.
- 这种方法为探索患者衍生的脑瘤中的代谢漏洞开辟了道路.
- 能够在3D脑癌模型中对代谢重编程进行详细分析.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Excretion
214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution
271
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
271
Pharmacokinetics in Pediatric Patients: Drug Metabolism
199
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
199
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
260
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
260
Responses to Salt Stress
14.5K
Salt stress—which can be triggered by high salt concentrations in a plant’s environment—can significantly affect plant growth and crop production by influencing photosynthesis and the absorption of water and nutrients.
14.5K
Responses to Heat and Cold Stress
14.7K
Every organism has an optimum temperature range within which healthy growth and physiological functioning can occur. At the ends of this range, there will be a minimum and maximum temperature that interrupt biological processes.
14.7K


